ZFP28 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.984000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.534000E-01
Normal-vs-Stage2
1.781550E-02
Normal-vs-Stage3
2.216200E-03
Normal-vs-Stage4
8.461200E-01
Stage1-vs-Stage2
1.612990E-01
Stage1-vs-Stage3
1.122820E-01
Stage1-vs-Stage4
3.544800E-01
Stage2-vs-Stage3
2.132200E-01
Stage2-vs-Stage4
2.237800E-01
Stage3-vs-Stage4
1.294220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.036100E-02
Normal-vs-AfricanAmerican
3.379800E-02
Normal-vs-Asian
1.713790E-02
Caucasian-vs-AfricanAmerican
7.207800E-01
Caucasian-vs-Asian
3.490200E-01
AfricanAmerican-vs-Asian
7.292400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.670100E-02
Normal-vs-Female
1.008790E-01
Male-vs-Female
1.429370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.010000E-01
Normal-vs-Age(41-60Yrs)
1.055440E-01
Normal-vs-Age(61-80Yrs)
3.861700E-02
Normal-vs-Age(81-100Yrs)
1.085680E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.244200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.023560E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.881800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.783800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.311580E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.867600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.431530E-02
Normal-vs-Daily Drinker
4.964900E-03
Normal-vs-Weekly Drinker
2.416000E-02
Normal-vs-Occasional Drinker
3.506200E-01
Normal-vs-Social Drinker
1.698380E-01
Non Drinker-vs-Daily Drinker
3.356800E-01
Non Drinker-vs-Weekly Drinker
7.266400E-01
Non Drinker-vs-Occasional Drinker
1.406220E-01
Non Drinker-vs-Social Drinker
1.673390E-01
Daily Drinker-vs-Weekly Drinker
2.508200E-01
Daily Drinker-vs-Occasional Drinker
4.339600E-02
Daily Drinker-vs-Social Drinker
4.484000E-02
Weekly Drinker-vs-Occasional Drinker
2.836600E-01
Weekly Drinker-vs-Social Drinker
3.714400E-01
Occasional Drinker-vs-Social Drinker
7.623600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.911600E-02
Normal-vs-Grade 2
3.839500E-02
Normal-vs-Grade 3
1.355170E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.511170E-01
Grade 1-vs-Grade 3
3.065800E-01
Grade 1-vs-Grade 4
9.911600E-02
Grade 2-vs-Grade 3
7.139400E-01
Grade 2-vs-Grade 4
3.839500E-02
Grade 3-vs-Grade 4
1.355170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.743600E-02
Normal-vs-NonDiabetic
3.621800E-02
Diabetic-vs-NonDiabetic
8.858200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.504820E-03
Normal-vs-NoPancreatitis
4.259800E-02
Pancreatitis-vs-NoPancreatitis
2.801900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.323150E-01
Normal-vs-N1
2.015600E-02
N0-vs-N1
7.132800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.158300E-02
Normal-vs-TP53-NonMutant
1.478820E-01
TP53-Mutant-vs-TP53-NonMutant
3.862500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
